Biomarkers in Renal Cell Carcinoma: What Next? Ronald M. Bukowski Clinical Trial Report 27 January 2011 Pages: 87 - 89
Commentary: Implications of Cancer Managed as a “Chronic Illness” Maurie Markman Commentary 08 January 2011 Pages: 90 - 91
Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer Mohamed SalemJorge A. Garcia ReviewPaper 18 January 2011 Pages: 92 - 96
Ramucirumab (IMC-1121B): Monoclonal Antibody Inhibition of Vascular Endothelial Growth Factor Receptor-2 Jennifer Spratlin ReviewPaper 12 January 2011 Pages: 97 - 102
Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status Pankaj BhargavaMurray O. Robinson ReviewPaper Open access 12 February 2011 Pages: 103 - 111
Sipuleucel-T: Prototype for Development of Anti-tumor Vaccines Estrella CarballidoMayer Fishman ReviewPaper 18 January 2011 Pages: 112 - 119
Quality of Care in Head and Neck Cancer Carol M. LewisRandal S. WeberEhab Y. Hanna ReviewPaper 06 January 2011 Pages: 120 - 125
Changing the Perspective: Current Trends in the Assessment of Functional Outcome in Patients with Head and Neck Cancer Uta Tschiesner ReviewPaper 01 February 2011 Pages: 126 - 131
Second Primary Tumors in Patients with Head and Neck Cancer Antonio Vitor Martins PrianteEmanuel Celice CastilhoLuiz Paulo Kowalski ReviewPaper 14 January 2011 Pages: 132 - 137
Endoscopic Resection of Sinonasal Malignancies Piero NicolaiPaolo CastelnuovoAndrea Bolzoni Villaret ReviewPaper 18 January 2011 Pages: 138 - 144
Oral Dysplasia: Biomarkers, Treatment, and Follow-up Paul NankivellHisham Mehanna ReviewPaper 20 January 2011 Pages: 145 - 152
